BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 35111249)

  • 1. Revisiting therapeutic strategies for ovarian cancer by focusing on redox homeostasis.
    Kobayashi H; Imanaka S; Shigetomi H
    Oncol Lett; 2022 Mar; 23(3):80. PubMed ID: 35111249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDA-7/IL-24 inhibits Nrf2-mediated antioxidant response through activation of p38 pathway and inhibition of ERK pathway involved in cancer cell apoptosis.
    Tian H; Zhang D; Gao Z; Li H; Zhang B; Zhang Q; Li L; Cheng Q; Pei D; Zheng J
    Cancer Gene Ther; 2014 Oct; 21(10):416-26. PubMed ID: 25236495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen potentiates reactive oxygen species (ROS) tolerance to initiate carcinogenesis and promote cancer malignant transformation.
    Tian H; Gao Z; Wang G; Li H; Zheng J
    Tumour Biol; 2016 Jan; 37(1):141-50. PubMed ID: 26566628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.
    Cheng X; Ku CH; Siow RC
    Free Radic Biol Med; 2013 Sep; 64():4-11. PubMed ID: 23880293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease.
    Giordano S; Darley-Usmar V; Zhang J
    Redox Biol; 2014; 2():82-90. PubMed ID: 24494187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interplay between reactive oxygen species and antioxidants in cancer progression and therapy: a narrative review.
    Bekhet OH; Eid ME
    Transl Cancer Res; 2021 Sep; 10(9):4196-4206. PubMed ID: 35116715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Applications of NRF2 Modulators in Cancer Therapy.
    Panieri E; Buha A; Telkoparan-Akillilar P; Cevik D; Kouretas D; Veskoukis A; Skaperda Z; Tsatsakis A; Wallace D; Suzen S; Saso L
    Antioxidants (Basel); 2020 Feb; 9(3):. PubMed ID: 32106613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of antioxidant gene expression by Nrf2 protects against mitochondrial dysfunction and neuronal death associated with acute and chronic neurodegeneration.
    Goodfellow MJ; Borcar A; Proctor JL; Greco T; Rosenthal RE; Fiskum G
    Exp Neurol; 2020 Jun; 328():113247. PubMed ID: 32061629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells.
    Zhang L; Zhang J; Jin Y; Yao G; Zhao H; Qiao P; Wu S
    Front Cell Dev Biol; 2021; 9():728172. PubMed ID: 34589492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial superoxide contributes to oxidative stress exacerbated by DNA damage response in RAD51-depleted ovarian cancer cells.
    Xu L; Wu T; Lu S; Hao X; Qin J; Wang J; Zhang X; Liu Q; Kong B; Gong Y; Liu Z; Shao C
    Redox Biol; 2020 Sep; 36():101604. PubMed ID: 32554304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of chemopreventive phytochemicals in NRF2-mediated redox homeostasis in humans.
    Chun KS; Raut PK; Kim DH; Surh YJ
    Free Radic Biol Med; 2021 Aug; 172():699-715. PubMed ID: 34214633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous Activation of Nrf2 and Elevation of Dietary and Endogenous Antioxidant Chemicals for Cancer Prevention in Humans.
    Prasad KN
    J Am Coll Nutr; 2016; 35(2):175-84. PubMed ID: 26151600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Reductive versus Oxidative Stress in Tumor Progression and Anticancer Drug Resistance.
    Chun KS; Kim DH; Surh YJ
    Cells; 2021 Mar; 10(4):. PubMed ID: 33808242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting antioxidants for cancer therapy.
    Glasauer A; Chandel NS
    Biochem Pharmacol; 2014 Nov; 92(1):90-101. PubMed ID: 25078786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
    Hyeon S; Lee H; Yang Y; Jeong W
    Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damage.
    Kim H; Lee GR; Kim J; Baek JY; Jo YJ; Hong SE; Kim SH; Lee J; Lee HI; Park SK; Kim HM; Lee HJ; Chang TS; Rhee SG; Lee JS; Jeong W
    Free Radic Biol Med; 2016 Feb; 91():264-74. PubMed ID: 26721593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the New Cancer Therapy through Redox Homeostasis and Metabolic Shifts.
    Hyun DH
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32645959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
    Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
    Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway.
    Qaisiya M; Coda Zabetta CD; Bellarosa C; Tiribelli C
    Cell Signal; 2014 Mar; 26(3):512-20. PubMed ID: 24308969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.